Potential benefit of Sunitinib in recurrent and refractory ovarian clear cell adenocarcinoma

scientific article

Potential benefit of Sunitinib in recurrent and refractory ovarian clear cell adenocarcinoma is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1111/J.1525-1438.2007.01156.X
P698PubMed publication ID18081793

P2093author name stringPenson RT
Rauh-Hain JA
P433issue5
P921main subjectadenocarcinomaQ356033
P304page(s)934-936
P577publication date2007-12-13
P1433published inInternational Journal of Gynecological CancerQ15749181
P1476titlePotential benefit of Sunitinib in recurrent and refractory ovarian clear cell adenocarcinoma
P478volume18